Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06198023 · ClinicalTrials.gov registry record · NA

Targeting Social Function in Anxiety and Eating Disorders

A NA study of Anorexia Nervosa and Eating Disorders, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06198023: Recruiting NA study of Anorexia Nervosa and Eating Disorders, sponsored by University of Texas Southwestern Medical Center.

NCT06198023 is a NA study of Anorexia Nervosa and Eating Disorders that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06198023, a NA study of Anorexia Nervosa and Eating Disorders, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Social processing and cognition are often altered in patients with eating disorders. The goal of this clinical trial is to assess two different social therapeutic interventions -- one educational, one interactive -- for their effectiveness in improving clinical outcomes in patients with eating disorders. Patients in both interventions will receive education about social function in eating disorders, but those in the interactive treatment group will complete an additional collaborative art task. Participants will: * attend a baseline study visit to complete clinical interviews, cognitive testing, and behavioral tasks * complete a pre-intervention assessment with questionnaires * attend eight sessions of their assigned treatment group over the course of 12 weeks * complete three virtual follow-up assessments 4, 8, and 12 months from their baseline * attend a final study visit to repeat some clinical interviews, cognitive testing, and behavioral tasks Researchers will compare changes in eating disorder, mood, and anxiety symptoms as well as test results from baseline and final study visits for each group to see if * patients can be treated effectively with education alone or if an interactive group component produces additional benefits * cognitive and behavioral task performance are associated with recovery or illness state.

Primary Outcome

The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder symptoms. Possible scores on global eating disorder pathology range from 0 to 6, with higher scores indicating greater severity. Scores of 2 or less are considered typical of normative eating behavior/cognitions, while scores of 3-6 suggest the presence of clinically significant eating disorder symptoms.

Interventions

  • BEHAVIORAL Educational
  • BEHAVIORAL Interactive

Study Locations (1)

Texas

  • UT Southwestern Multispecialty Psychiatry Clinic - Dallas

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-02-28
Est. Completion 2028-09
Phase NA

What NCT06198023 shows while recruiting

NCT06198023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (94% lower).

The record links to 8 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Educational is the first listed.

NCT06198023 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06198023 about?

NCT06198023 is a clinical study titled "Targeting Social Function in Anxiety and Eating Disorders". Social processing and cognition are often altered in patients with eating disorders. The goal of this clinical trial is to assess two different social therapeutic interventions -- one educational, one interactive -- for their effectiveness in improving clinical outcomes in patients with eating disor...

What is the current status of trial NCT06198023?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-28. Estimated completion is 2028-09.

What conditions does trial NCT06198023 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Eating Disorders, Social Anxiety Disorder, Bulimia Nervosa, Generalized Anxiety Disorder (GAD).

What interventions are being tested in trial NCT06198023?

The interventions under investigation include: Educational (BEHAVIORAL), Interactive (BEHAVIORAL).

Who is sponsoring clinical trial NCT06198023?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06198023 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06198023's enrollment target sits among peer trials

60 21st of 43 higher than 23 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06198023, the US trial registry maintained by the National Library of Medicine. NCT06198023 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.